Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

OriGene Buys Zhongshan Golden Bridge Biotechnology

publication date: Mar 13, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
OriGene Technologies, a research tool maker from the Washington DC area, acquired Beijing Zhongshan Golden Bridge Biotechnology (ZsBio) for an undisclosed sum. Founded in Beijing in 1993, ZsBio provides pathology testing products for China’s oncology diagnostic market. OriGene said the acquisition takes it into the pathology testing market for the first time, while also giving it a leading position in this sector of the Chinese market. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...